Documentation scienceplus.abes.fr version Bêta

À propos de : Monthly immunoglobulin therapy improved relapsing-remitting multiple sclerosis        

AttributsValeurs
type
Is Part Of
Subject
Title
  • Monthly immunoglobulin therapy improved relapsing-remitting multiple sclerosis
has manifestation of work
Abstract
  • FazekasFDeisenhammerFStrasser-FuchsSNahlerGMamoliB, for the Austrian Immunoglobulin in Multiple Sclerosis Study Group. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Lancet. 1997 Mar 1;349:589-93.
article type
publisher identifier
  • ebmed2112
is part of this journal



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata